218 related articles for article (PubMed ID: 30417125)
1. APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R.
Okamoto K; Rausch JW; Wakashin H; Fu Y; Chung JY; Dummer PD; Shin MK; Chandra P; Suzuki K; Shrivastav S; Rosenberg AZ; Hewitt SM; Ray PE; Noiri E; Le Grice SFJ; Hoek M; Han Z; Winkler CA; Kopp JB
Commun Biol; 2018; 1():188. PubMed ID: 30417125
[No Abstract] [Full Text] [Related]
2. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
[TBL] [Abstract][Full Text] [Related]
3. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress.
Wakashin H; Heymann J; Roshanravan H; Daneshpajouhnejad P; Rosenberg A; Shin MK; Hoek M; Kopp JB
BMC Nephrol; 2020 Aug; 21(1):371. PubMed ID: 32854642
[TBL] [Abstract][Full Text] [Related]
4. APOL1 kidney risk variants in glomerular diseases modeled in transgenic mice.
Yoshida T; Latt KZ; Santo BA; Shrivastav S; Zhao Y; Fenaroli P; Chung JY; Hewitt SM; Tutino VM; Sarder P; Rosenberg AZ; Winkler CA; Kopp JB
bioRxiv; 2023 Mar; ():. PubMed ID: 37090576
[No Abstract] [Full Text] [Related]
5. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
6. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
[TBL] [Abstract][Full Text] [Related]
7. Lessons From APOL1 Animal Models.
Yoshida T; Latt KZ; Heymann J; Kopp JB
Front Med (Lausanne); 2021; 8():762901. PubMed ID: 34765626
[TBL] [Abstract][Full Text] [Related]
8. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
9. Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys.
Blessing NA; Wu Z; Madhavan SM; Choy JW; Chen M; Shin MK; Hoek M; Sedor JR; O'Toole JF; Bruggeman LA
PLoS One; 2021; 16(6):e0253197. PubMed ID: 34138902
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.
Lan X; Wen H; Saleem MA; Mikulak J; Malhotra A; Skorecki K; Singhal PC
Exp Mol Pathol; 2015 Jun; 98(3):491-501. PubMed ID: 25796344
[TBL] [Abstract][Full Text] [Related]
11. A tripartite complex of suPAR, APOL1 risk variants and α
Hayek SS; Koh KH; Grams ME; Wei C; Ko YA; Li J; Samelko B; Lee H; Dande RR; Lee HW; Hahm E; Peev V; Tracy M; Tardi NJ; Gupta V; Altintas MM; Garborcauskas G; Stojanovic N; Winkler CA; Lipkowitz MS; Tin A; Inker LA; Levey AS; Zeier M; Freedman BI; Kopp JB; Skorecki K; Coresh J; Quyyumi AA; Sever S; Reiser J
Nat Med; 2017 Aug; 23(8):945-953. PubMed ID: 28650456
[TBL] [Abstract][Full Text] [Related]
12. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
Lan X; Jhaveri A; Cheng K; Wen H; Saleem MA; Mathieson PW; Mikulak J; Aviram S; Malhotra A; Skorecki K; Singhal PC
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F326-36. PubMed ID: 24899058
[TBL] [Abstract][Full Text] [Related]
13. APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
Bruggeman LA; Wu Z; Luo L; Madhavan SM; Konieczkowski M; Drawz PE; Thomas DB; Barisoni L; Sedor JR; O'Toole JF
J Am Soc Nephrol; 2016 Dec; 27(12):3600-3610. PubMed ID: 27026370
[TBL] [Abstract][Full Text] [Related]
14. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
16. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
17. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
Ma L; Shelness GS; Snipes JA; Murea M; Antinozzi PA; Cheng D; Saleem MA; Satchell SC; Banas B; Mathieson PW; Kretzler M; Hemal AK; Rudel LL; Petrovic S; Weckerle A; Pollak MR; Ross MD; Parks JS; Freedman BI
J Am Soc Nephrol; 2015 Feb; 26(2):339-48. PubMed ID: 25012173
[TBL] [Abstract][Full Text] [Related]
18.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
19. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
[TBL] [Abstract][Full Text] [Related]
20. APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.
Madhavan SM; O'Toole JF; Konieczkowski M; Barisoni L; Thomas DB; Ganesan S; Bruggeman LA; Buck M; Sedor JR
JCI Insight; 2017 Jul; 2(14):. PubMed ID: 28724794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]